Arteriovenous malformations (AVMs) of the central nervous system are considered as congenital disorders. They are composed of abnormally developed dilated arteries and veins and are characterized microscopically by the absence of a capillary network. We previously reported DNA fragmentation and increased expression of apoptosis-related factors in AVM lesions. In this article, we used microarray analysis to examine differential gene expression in relation to clinical manifestations in 11 AVM samples from Japanese patients. We categorized the genes with altered expression into four groups: deathrelated, neuron-related, inflammation-related, and other. The death-related differentially expressed genes were MMP9, LIF, SOD2, BCL2A1, MMP12, and HSPA6. The neuron-related genes were NPY, S100A9, NeuroD2, S100Abeta, CAMK2A, SYNPR, CHRM2, and CAMKV. The inflammation-related genes were PTX3, IL8, IL6, CXCL10, GBP1, CHRM3, CXCL1, IL1R2, CCL18, and CCL13. In addition, we compared gene expression in those with or without clinical characteristics including deep drainer, embolization, and high-flow nidus. We identified a small number of genes. Using these microarray data we are able to generate and test new hypotheses to explore AVM pathophysiology. Microarray analysis is a useful technique to study clinical specimens from patients with brain vascular malformations.
Introduction
arteriovenous malformations (aVMs) of the central nervous system are generally considered as congenital disorders that result from aberrant differentiation of the mesoderm during embryonic development. aVMs are composed of abnormally developed dilated arteries and veins and are characterized microscopically by the absence of a capillary network. [1] [2] [3] [4] although many studies have addressed the epidemiological characteristics, natural history, radiological features, and clinical behavior of aVMs, less is known about the molecular properties of these lesions. [1] [2] [3] [4] recent studies have revealed abnormal expression of angiogenic growth factors and their receptors compared with that in normal brain tissue. [5] [6] [7] [8] Moreover, we have reported that aVM lesions display dna fragmentation and increased expression of apoptosis-related factors. [9] [10] [11] in this study, we examined differential gene expression in aVMs and analyzed this expression in relation to clinical manifestations in Japanese patients.
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three times for 20 sec on ice. after the addition of 0.1 vol 1-bromo-3-chloropropane, the homogenate was vortexed for 15 sec and incubated on ice for 1 hr. after centrifugation, the upper aqueous phase was transferred to a new tube and a half volume of isopropanol was added. The solution was then mixed and incubated on ice for 1 hr. after centrifugation, the supernatant was removed. The rna pellet was washed with 80% ethanol and resuspended in diethylpyrocarbonate-treated water. The rna was affinity column-purified using an rneasy Mini kit (Qiagen inc., Valencia, California, usa) according to the manufacturer's protocol. Control rna was extracted from a middle cerebral artery and a cortical tissue sample from a Caucasian male.
III. Microarray analysis
Microarray analysis was conducted by hokkaido system science Co. Ltd. (sapporo). Total rna was extracted from three biological replicates of each sample, and then it was used for crna synthesis. The resulting crna was subsequently labeled with Cyanin3 using a Quick amp Labeling kit (agilent Technologies inc., santa Clara, California, usa), and purified using rneasy mini spin columns (Qiagen) to generate the crna target solution. The crna target solution was then hybridized to the microarray (arabidopsis oligo dna microarray ver. 4.0; agilent Technologies). after washing and air-drying, the slide was scanned at a resolution of 5 µm using a microarray scanner (agilent Technologies). The digitalized data were imported into software (genespring gX 10; agilent Technologies) and normalized to shift to the 75th percentile. The following flagged features were cut off: features that were not positive and significant, and features that were not above background levels. after filtering for flags, 32 348 probes remained. on the microarray, some genes are represented by several oligonucleotides that have distinct 60-mer sequences from different regions within the same gene. Tables 2 and 3 indicate the genes that displayed an absolute fold change of at least ± 300. we categorized these genes into four groups: deathrelated, neuron-related, inflammation-related, and others. The differentially expressed death-related genes were MMP9, LIF, SOD2, BCL2A1, MMP12, and HSPA6. The neuron-related genes were NPY, S100A9, NeuroD2, S100Abeta, CAMK2A, SYNPR, CHRM2, and CAMKV. The inflammation-related genes were PTX3, IL8, IL6, CXCL10, GBP1, CHRM3, CXCL1, IL1R2, CCL18, and CCL13. in addition, we classified significantly changed genes based on biological process and molecular function (Fig. 1) .
Results
next, we analyzed gene expression in relation to clinical characteristics. First, we analyzed gene expression in the samples that were or were not from deep-draining veins. we identified 32 genes that showed greater than 10-fold change in deep-draining samples (Table 4) . among them, FGF9, which is an angiogenesis-related gene, was upregulated. we next compared gene expression in those with or without preoperative embolization, and found 21 genes that showed a greater than 10-fold change in those with embolization (Table 5) . among them, PTX3, MMP3, and GDNF were downregulated in the samples with preoperative embolization. when we compared expression in the samples with or without a highflow nidus, we identified 40 genes with a greater than 10-fold change in samples with high flow (Table 6) . neuron-related genes, including NPY and NeuroD, were downregulated in high-flow aVMs.
Discussion
aVMs seem to have unique and relatively homogeneous molecular abnormalities that can be detected at the mrna and protein levels. Most studies have focused on the abnormal expression of vascular endothelial growth factor and its receptors 3, 8, [12] [13] [14] [15] or angiogenesis or cell death-related factors and receptors. Moreover, we reported that the death receptor pathway and the nF-kappaB pathway were upregulated in aVMs. 9, 11) These results indicate that dynamic vascular remodeling and neuronal death occur in and around the nidus of aVMs. [16] [17] [18] [19] [20] The majority of these studies, however, have focused on only one or a few genes or protein products. here, using microarray analysis, we were able to dissect numerous molecular pathways that interact with or counteract each other within the same samples. our findings were, in general, consistent with previously published findings, especially for genes showing a statistically significant difference between aVMs and controls. 3, 8, 12, 15, 21) one previous study reported an increase in iL6 protein levels in aVM tissue. in addition, the gg genotype of the IL6 174g > C promoter polymorphism was associated with the clinical presentation of intracranial hemorrhage in aVMs. 8, 13) as for MMP9, hashimoto et al. 22) reported that aVM samples had higher levels of total MMP9, active MMP9, pro-MMP9, TiMP1, and TiMP3 than controls. in contrast, TiMP4 levels were higher in the control brain than in the aVM specimens. in addition, MMP9 was reported to be localized to the endothelial cell/ peri-endothelial cell layer and infiltrating neutrophils of aVMs. regarding iL1, we found that IL1R2 was elevated in our aVM samples. Fontanella et al. 16) suggested that functional polymorphisms within the IL1 complex gene are associated with aVMs and influence the clinical characteristics of the disease, supporting a role for proinflammatory cytokines in disease etiopathogenesis. 23) IL1β promoter polymorphisms were reported to be associated with aVM susceptibility and an increased risk of intracranial hemorrhage in the aVM clinical course. 16, 23) These results suggest that the inflammatory pathways, including the iL1β cytokine, play an important role in intracranial hemorrhage. in previous studies, elevated iL6 was strongly associated with iL8 and MMP12, which were both elevated at the gene level in this study. 8, 13) we and others have reported brain infiltration of various types of inflammatory cells in and around the nidus of aVMs. 10, 24) we identified several chemokine genes to be elevated in aVMs; chemokines may be released by these infiltrating cells. 10, 24) Previously we also showed reduced neuronal density around the nidus, 11) which may be related to our observed alterations in neuronrelated genes. our gene microarray data may help us to establish further hypotheses for testing. For example, microarray data showed inflammation-related genes including iL-8 and iL-6. These observations may lead us to anti-inflammatory treatment against aVMs. To establish this hypothesis, further study is necessary to confirm that inflammation increase the risk of aVM rupture. in addition, MMP family including MMP9, MMP12, and MMP3 changed. This observation may lead us to perform other further analysis using MMP inhibitors.
Fig. 1 Classified genes with significantly altered expression based on biological process (A) and molecular function (B).
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in this study, we analyze gene expression focusing on the neuron-, death-, angiogenesis-, and inflammation-related genes. Because we and others indicated the role of these pathways in cerebral aVMs. 5, [9] [10] [11] [12] [13] [14] 16, 21, 23, 24) decreased expression of neuronrelated genes indicate the loss of neurons in and around the nidus. increased expressions of deathrelated genes indicate cellular death of neurons, infiltrating and vascular cells. in addition, increased expression of angiogenesis and inflammation-related genes may show upregulation of these events.
we also analyzed associations between gene expression and the clinical presentation or treatment of aVMs (the presence or absence of hemorrhage, deep-draining veins, embolization, and high-flow), focusing on the neuron-, death-, angiogenesis-, and inflammation-related genes. a deep-draining system may cause venous congestion, which can lead to neuronal loss. however, our data did not indicate neuronal loss because FGF9, which can induce angiogenesis, was upregulated. we focused on inflammation-related genes in relation to preoperative embolization, and demonstrated downregulation of several genes in embolized samples. This may indicate that these changes are not related to preoperative embolization but instead to the operative process itself (two of these samples had intraoperative hemorrhage). in the high-flow samples, neuron-related genes, including neuropeptide Y (NPY), synaptotagmin 1 (SYT1), neurogenic differentiation 2 (NeuroD), and ephrin B3 (EFNB3) were downregulated. This may indicate that neurons and neuronal networks were injured in high-flow aVMs, and may correlate with our previous finding of neuronal loss in the perinidal area. 11) one of the limitations of this study, and of most previous studies, is the small sample size, which can lead to false-negative or false-positive results. Clinical samples may show significant variation in the levels of a specific gene or its product, which may reflect different stages and severity of the disease or simply interindividual variation. one more limitation of the study, during surgical process gene expression may be affected with local ischemia, inflammation, mechanical compression and coagulation. Microarray analysis on a large number of clinical specimens with a well-characterized clinical background is necessary to validate our findings. in addition, it should be noted that the correlation between gene expression and that of its Neurol Med Chir (Tokyo) 54, March, 2014 
